California’s Bay Area has been one of the largest biotech hubs in the world, and as such, available space has become an issue for startups and smaller companies. A new life sciences development in San Carlos, California will provide some needed elbow room.
Presidio Bay Ventures partnered with Kinship Capital to acquire a piece of property in the Northern California city to redevelop into a space for the life sciences industry. According to Presidio Bay Ventures, a commercial real estate development firm, the property located at 777 Industrial Road will be redeveloped into a 123,000-square-foot Class A life sciences building with high-quality materials and cutting-edge functionality. San Carlos is home to companies like Alkahest, Paramune and ChemoCentryx, Inc.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,